Difference between revisions of "3M Pharmaceuticals"
(starting new page) |
(removed PhRMA affiliation - ref not found) |
||
| Line 4: | Line 4: | ||
==Affiliations== | ==Affiliations== | ||
| − | + | ||
==References== | ==References== | ||
Revision as of 13:42, 15 December 2007
In the latter part of 2006, Meda announced completion its acquisition of the pharmaceutical division of 3M in Europe. [1]
At the same time, 3M announced that it had agreed to sell its pharmaceutical operations in the United States, Canada, and Latin America region to Graceway Pharmaceuticals Inc. at a cost of $875million. 3M's pharmaceutical operations in the Asia Pacific region (including Australia and South Africa) were also sold to Ironbridge Capital and Archer Capital. [2]
Affiliations
References
- ↑ Zenopa Meda completes 3M Pharmaceuticals acquisition in Europe Eccessed 15th December 2007
- ↑ 3M 3M Reaches Agreements to Sell its Pharmaceuticals Business Accessed 15th December 2007
